International Journal of Cancer Management

Published by: Kowsar
Crossmark

Treatment Outcomes and Prognostic Factors in Adult Astrocytoma: In North East of Iran

Kazem Anvari 1 , Mehdi Seilanian Toussi 1 , * , Soodabeh Shahidsales 1 , Farhad Motlagh 2 , Mohammad Reza Ehsaee 3 and Farzaneh Afshari 4
Authors Information
1 Cancer Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, IR Iran
2 Department of Neurosurgery, Aria & Farabi Hospitals, Faculty of Medicine, Mashhad Branch, Islamic Azad University, Mashhad, IR Iran
3 Department of Neurosurgery, Shahid Kamiab Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, IR Iran
4 Department of Radiation Oncology, Omid Hospital, Mashhad University of Medical Sciences, Mashhad, IR Iran
Article information
  • Iranian Journal of Cancer Prevention: August 2016, 9 (4); e4099
  • Published Online: March 26, 2016
  • Article Type: Research Article
  • Received: September 21, 2015
  • Accepted: November 7, 2015
  • DOI: 10.17795/ijcp-4099

How to Cite: Anvari K, Seilanian Toussi M, Shahidsales S, Motlagh F, Reza Ehsaee M, et al. Treatment Outcomes and Prognostic Factors in Adult Astrocytoma: In North East of Iran, Int J Cancer Manag. 2016 ; 9(4):e4099. doi: 10.17795/ijcp-4099.

Abstract
Copyright © 2016, Iranian Journal of Cancer Prevention. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Kleihues P, Burger PC, Scheithauer BW. The new WHO classification of brain tumours. Brain Pathol. 1993; 3(3) : 255 -68 [DOI]
  • 2. Heath A. Principles and practice of radiation oncology. 2008;
  • 3. CBTRUS Statistical Report . Primary brain and central nervous system tumors diagnosed in the united states in 2004-2007. 2012;
  • 4. Seilanian Toussi M, Anvari K. Treatment outcomes of astrocytoma. 2004; 47 : 355 -60
  • 5. Daniels TB, Brown PD, Felten SJ, Wu W, Buckner JC, Arusell RM, et al. Validation of EORTC prognostic factors for adults with low-grade glioma: a report using intergroup 86-72-51. Int J Radiat Oncol Biol Phys. 2011; 81(1) : 218 -24 [DOI][PubMed]
  • 6. Waqar M, Hanif S, Brodbelt AR, Rathi N, Das K, Zakaria R, et al. Prognostic Factors in Lobar World Health Organization Grade II Astrocytomas. World Neurosurg. 2015; 84(1) : 154 -62 [DOI][PubMed]
  • 7. Shaw EG, Wisoff JH. Prospective clinical trials of intracranial low-grade glioma in adults and children. Neuro Oncol. 2003; 5(3) : 153 -60 [DOI][PubMed]
  • 8. Kilic T, Ozduman K, Elmaci I, Sav A, Necmettin Pamir M. Effect of surgery on tumor progression and malignant degeneration in hemispheric diffuse low-grade astrocytomas. J Clin Neurosci. 2002; 9(5) : 549 -52 [PubMed]
  • 9. McGirt MJ, Chaichana KL, Attenello FJ, Weingart JD, Than K, Burger PC, et al. Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas. Neurosurgery. 2008; 63(4) : 700 -7 [DOI][PubMed]
  • 10. Pignatti F, van den Bent M, Curran D, Debruyne C, Sylvester R, Therasse P, et al. Prognostic factors for survival in adult patients with cerebral low-grade glioma. J Clin Oncol. 2002; 20(8) : 2076 -84 [PubMed]
  • 11. Berger MS, Deliganis AV, Dobbins J, Keles GE. The effect of extent of resection on recurrence in patients with low grade cerebral hemisphere gliomas. Cancer. 1994; 74(6) : 1784 -91 [PubMed]
  • 12. Durmaz R, Vural M, Isildi E, Cosan E, Ozkara E, Bal C, et al. Efficacy of prognostic factors on survival in patients with low grade glioma. Turk Neurosurg. 2008; 18(4) : 336 -44 [PubMed]
  • 13. Leighton C, Fisher B, Bauman G, Depiero S, Stitt L, MacDonald D, et al. Supratentorial low-grade glioma in adults: an analysis of prognostic factors and timing of radiation. J Clin Oncol. 1997; 15(4) : 1294 -301 [PubMed]
  • 14. Catalan-Uribarrena G, Bilbao-Barandica G, Pomposo-Gaztelu I, Undabeitia-Huertas J, Ruiz de Gopegui-Ruiz E, Galbarriatu-Gutierrez L, et al. Prognostic factors and survival in a prospective cohort of patients with high-grade glioma treated with carmustine wafers or temozolomide on an intention-to-treat basis. Acta Neurochir (Wien). 2012; 154(2) : 211 -22 [DOI][PubMed]
  • 15. Laws ER, Parney IF, Huang W, Anderson F, Morris AM, Asher A, et al. Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project. J Neurosurg. 2003; 99(3) : 467 -73 [DOI][PubMed]
  • 16. Wurschmidt F, Bunemann H, Heilmann HP. Prognostic factors in high-grade malignant glioma. A multivariate analysis of 76 cases with postoperative radiotherapy. Strahlenther Onkol. 1995; 171(6) : 315 -21 [PubMed]
  • 17. McCrea HJ, Bander ED, Venn RA, Reiner AS, Iorgulescu JB, Puchi LA, et al. Sex, Age, Anatomic Location, and Extent of Resection Influence Outcomes in Children With High-grade Glioma. Neurosurgery. 2015; 77(3) : 443 -52 [DOI][PubMed]
  • 18. Simpson JR, Horton J, Scott C, Curran WJ, Rubin P, Fischbach J, et al. Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: Results of three consecutive radiation therapy oncology group (rtog) clinical trials. Int J Radiat Oncol Biol Phys. 1993; 26(2) : 239 -44 [DOI]
  • 19. Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, DeMonte F, et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg. 2001; 95(2) : 190 -8 [DOI]
  • 20. Buckner JC. Factors influencing survival in high-grade gliomas. Semin Oncol. 2003; 30(6 Suppl 19) : 10 -4 [PubMed]
  • 21. Barker F2, Chang SM, Gutin PH, Malec MK, McDermott MW, Prados MD, et al. Survival and functional status after resection of recurrent glioblastoma multiforme. Neurosurgery. 1998; 42(4) : 709 -20 [PubMed]
  • 22. Wu W, Lamborn KR, Buckner JC, Novotny PJ, Chang SM, O'Fallon JR, et al. Joint NCCTG and NABTC prognostic factors analysis for high-grade recurrent glioma. Neuro Oncol. 2010; 12(2) : 164 -72 [DOI][PubMed]
  • 23. Stewart LA. Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet. 2002; 359(9311) : 1011 -8 [PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments